Table 4. Effectiveness of treatment modalities in new hepatic tumour and new distal metastasis.
Variables | HAIC (n=70), n (%) | Systemic ICI (n=46), n (%) | HAIC and ICI (n=14), n (%) | P value |
---|---|---|---|---|
Recurrent of new hepatic tumour, yes (%) | 20 (28.57) | 8 (17.39) | 1 (7.14) | 0.130 |
Recurrent of new distal metastasis, yes (%) | 7 (10.00) | 11 (23.91) | 4 (28.57) | 0.069 |
HAIC, hepatic arterial infusion chemotherapy; ICI, immune checkpoint inhibitor.